Ménétrier Syndrome

Ménétrier Syndrome

A rare hyperproliferative gastropathy characterized by massive folds in the stomach wall, resulting in protein loss and hypochlorhydria.

Key Points

  • Also known as Giant Hypertrophic Gastritis
  • Rare disease affecting both adults and children
  • Associated with increased risk of gastric cancer
  • Different clinical course in children vs adults
  • Linked to excessive TGF-α production

Clinical Manifestations

Common Symptoms

  • Gastrointestinal:
    • Epigastric pain
    • Nausea and vomiting
    • Early satiety
    • Anorexia
    • Weight loss
  • Systemic manifestations:
    • Peripheral edema
    • Fatigue
    • Muscle weakness
    • Growth delay in children

Age-Specific Features

  • Pediatric presentation:
    • Usually acute onset
    • Often self-limiting
    • Associated with CMV infection
    • Better prognosis
  • Adult presentation:
    • Chronic progressive course
    • Higher cancer risk
    • More severe protein loss
    • Often requires surgical intervention

Diagnostic Approach

Laboratory Studies

  • Serum studies:
    • Serum albumin (typically decreased)
    • Total protein
    • Complete blood count
    • Electrolytes
    • Gastrin levels
  • Other tests:
    • 24-hour urinary protein
    • Stool alpha-1 antitrypsin
    • CMV testing in children
    • H. pylori testing

Imaging Studies

  • Endoscopic findings:
    • Enlarged gastric folds
    • Typically sparing antrum
    • Eroded or polypoid surface
    • Thick mucous coating
  • Radiologic studies:
    • CT scan
    • Upper GI series
    • Endoscopic ultrasound

Histopathology

  • Key features:
    • Foveolar hyperplasia
    • Glandular atrophy
    • Reduced parietal cells
    • Increased mucous cells
    • Minimal inflammation
  • Required sampling:
    • Multiple deep biopsies
    • Full-thickness specimens

Management Strategies

Medical Management

  • Protein replacement:
    • Albumin infusions
    • High-protein diet
    • Nutritional support
  • Targeted therapy:
    • Cetuximab (EGFR inhibitor)
    • Octreotide
    • H2 blockers
    • Proton pump inhibitors

Surgical Management

  • Indications:
    • Severe symptoms
    • Refractory cases
    • Cancer risk
    • Complications
  • Procedures:
    • Total gastrectomy
    • Partial gastrectomy
    • Reconstructive options

Supportive Care

  • Nutritional support
  • Pain management
  • Regular monitoring
  • Psychological support

Pathophysiology & Recent Research

Molecular Mechanisms

  • Growth factor involvement:
    • Increased TGF-α expression
    • EGFR pathway activation
    • Altered cell proliferation
  • Associated factors:
    • CMV infection
    • H. pylori infection
    • Genetic predisposition

Disease Progression

  • Natural history:
    • Progressive in adults
    • Self-limiting in children
    • Cancer risk (10-15% in adults)
  • Monitoring requirements:
    • Regular endoscopy
    • Protein level monitoring
    • Cancer surveillance

Current Research

  • Therapeutic targets:
    • Novel EGFR inhibitors
    • Growth factor pathways
    • Immunological factors
  • Clinical trials:
    • Targeted therapies
    • Biomarker studies
    • Prognostic indicators


Further Reading
Powered by Blogger.